Pear Therapeutics, Inc.: eps_diluted

Value{"per": "shares", "amount": -0.13, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"}
Period2022-01-01 – 2022-06-30
Statuscurrent
EntityPear Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001835567-22-000069 · Open the official SEC filing →
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001835567/eps-diluted/2022-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e319e4ad-bd5d-4f96-bb4a-a40efbcc7920

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies